Research abstract
British Dental Journal 206, 627 - 631 (2009)
Published online: 27 June 2009 | doi:10.1038/sj.bdj.2009.519
Subject Categories: Nutrition | Periodontology
Calcium and vitamin D use among adults in periodontal disease maintenance programmes
D. Dixon1, C. F. Hildebolt2, D. D. Miley3, M. N. Garcia4, T. K. Pilgram5, R. Couture6, C. Anderson Spearie7 & R. Civitelli8
- Optimal intake of vitamin D and calcium slows bone resorption and ensures adequate calcium for bone mineralisation.
- Optimal levels of vitamin D should have an immunosuppressive effect on periodontal disease.
- Older adults, particularly those with dark skin colour and/or those who live in northern latitudes, should consider oral vitamin D supplementation.
Abstract
Objectives To determine the level of calcium and vitamin D oral supplementation in patients in periodontal disease maintenance programmes.
Design Convenience survey.
Setting St. Louis Metropolitan region.
Subjects and methods Patients (n = 228) in two university-based, periodontal disease maintenance programmes.
Main outcome measures Reported amounts of oral calcium and vitamin D supplementation were tested for differences based on gender and race.
Results The last published recommended daily intakes from the United States (US) Food and Nutrition Board (FNB) for adults >50 years of age are 1,200 mg calcium and 400 IU vitamin D (or 600 IU if over 70). The mean age of the 228 patients (125 females and 103 males) was 63.6
11.0 years (standard deviation). Of the 228 patients surveyed: (1) 204 (89%) were >50 years of age and of these, only 15 (7%) met the US FNB's recommended intakes of calcium and vitamin D from supplementation; (2) 138 (66%) reported that they took no oral supplementation, with significantly more males (n = 82) than females (n = 56) not taking supplementation (p = 0.03); (3) 88 (39%) took calcium supplementation, with females (947
511 mg/day) taking significantly (p <0.001) more than males (632
907 mg/day); and (4) 66 (29%) took vitamin D supplementation, with females(420
227 IU/day) taking approximately the same amount as males (443
317 IU/day, p >0.05). The amounts of oral supplementation did not vary with race (p >0.05).
Conclusion The use of calcium and vitamin D supplementation has been promoted for years, yet the numbers of adults taking supplements remains low and the level of supplementation varies greatly. Knowledge of the benefits of supplementation needs to be better disseminated and research needs to be conducted to determine optimal levels of calcium and vitamin D supplementation.
- Associate Professor/Head of Radiology, Southern Illinois University School of Dental Medicine, 2800 College Avenue, Alton, IL 62002, USA
- Professor of Radiology, Washington University School of Medicine, 510 South Kingshighway, St. Louis, MO 63110, USA
- Associate Professor, Southern Illinois University School of Dental Medicine and Saint Louis University Center for Advanced Dental Education, 3320 Rutger St., St. Louis, MO 63104, USA
- Clinical Assistant Professor, Southern Illinois University School of Dental Medicine and Saint Louis University Center for Advanced Dental Education, 3320 Rutger St., St. Louis, MO 63104, USA
- Instructor of Radiology, Washington University School of Medicine, 510 South Kingshighway, St. Louis, MO 63110, USA
- X-Ray Specialist, Radiology, Washington University School of Medicine, 510 South Kingshighway, St. Louis, MO 63110, USA
- Head Bionutritionist, General Clinical Research, Washington University School of Medicine, 510 South Kingshighway, St. Louis, MO 63110, USA
- Professor of Medicine, Cell Biology and Physiology and Orthopaedic Surgery, Washington University School of Medicine, 510 South Kingshighway, St. Louis, MO 63110, USA
Correspondence to: D. Dixon1
Dr Debra Dixon, D.M.D, M.Sc.
e-mail: ddixon@siue.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Therapy Insight: osteoporosis during hormone therapy for prostate cancer
Nature Clinical Practice Urology Review (01 Dec 2005)
Therapy Insight: osteoporosis during hormone therapy for prostate cancer
Nature Clinical Practice Urology Review (01 Dec 2005)
Drug Insight: existing and emerging therapies for osteoporosis
Nature Clinical Practice Endocrinology & Metabolism Review (01 Dec 2006)
Drug Insight: existing and emerging therapies for osteoporosis
Nature Clinical Practice Endocrinology & Metabolism Review (01 Dec 2006)
RESEARCH
European Journal of Clinical Nutrition Original Article
